2017 - Volume 2 - Issue 1 Articles
-
Review Article | ArticleFebruary 02, 2017 | Pages : 205 - 450Abstract Guanfacine extended release (GXR) is a a2A-adrenoreceptor agonist approved by the European Medicines Agency (EMA) in September 2015 for treatment of attention-deficit/hyperactivity disorder (ADHD) in child and young people (CYP) aged 6–17 year, whe.....
-
Research Article | ArticleFebruary 20, 2017 | Pages : 205 - 450Abstract This review examined the findings from the six most recent longitudinal studies of ADHD with a goal of answering the question of what the future likely holds for an individual with childhood ADHD. When the findings from these studies were combined wi.....
-
Short Communication | ArticleApril 04, 2017 | Pages : 205 - 450Abstract Background/Introduction: This article reports the process evaluation of a multi-center randomized controlled trial in which the effect of music therapy in Huntington’s Disease (HD) was studied. The beneficial affects of this complex intervention, r.....
-
Research Article | ArticleApril 10, 2017 | Pages : 205 - 450Abstract Context: Choking and accidental falls are common incidents in patients with Huntington’s disease (HD). It is not clear which emotional and cognitive factors contribute to the development of fear of choking (FoC) or fear of falling (FoF). Objectiv.....
